Sanofi-Aventis Canada Inc. v. Teva Canada Limited, 2012 FC 552 (Ramipril*)

Justice Snider - 2012-05-23

Read full decision. Automatically generated summary:

Teva Canada Limited (Teva), the Plaintiff by Counterclaim in this action, sells a generic version of ramipril – a drug used mainly to treat hypertension – into the Canadian market. Sanofi-Aventis Canada Inc. (Sanofi), one of the Defendants by Counterclaim in this action, holds or has held patent rights to a brand-name version of ramipril – ALTACE.

Decision relates to:


Canadian Intellectual Property